Abstract
ObjectiveCONCERTO was a randomised, double-blind, parallel-armed study of methotrexate (MTX) in combination with adalimumab to assess whether an increasing trend of efficacy and decreased safety exists when increasing MTX dose...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have